Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fricke

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Die Pharmazie|May 1, 1979
[Pharmacokinetics of turimycin (proceedings)]H Hoffmann, A Härtl, U Horn, et al.
The Journal of Antibiotics|June 1, 1978
Effect of demycarosylturimycin on ribosomal peptidyltransferase from Escherichia coliI Haupt, H Fricke, J Cerná, et al.
Journal of Environmental Monitoring : JEM|September 6, 2001
Comparison of two carbon analysis methods for monitoring diesel particulate levels in minesM E Birch, D Dahmann, H H Fricke
Kidney International|December 15, 2000
Proteinase 3 gene polymorphisms and Wegener's granulomatosisM Gencik, S Meller, S Borgmann, et al.
Die Pharmazie|January 1, 1976
[The physiology and biochemistry of Streptomycetes. 5. Isolation and identification of fatty acids from the macrolide antibiotic A 6599 (turimycin)]G Reuter, R Hüttner, H Fricke, et al.
Journal of Colloid and Interface Science|September 21, 2010
Clogging of microchannels by nano-particles due to hetero-coagulation in elongational flowK Georgieva, D J Dijkstra, H Fricke, et al.
Clinical and Experimental Immunology|July 15, 1999
Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patientsR F Schwabe, H Engelmann, S Hess, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Clinical aspects of biocompatibility]H Schiffl, S M Lang, C Keuneke, et al.
Die Pharmazie|November 1, 1983
[Protein binding of the macrolide antibiotic turimycin. Methodologic effects on results]G Hesse, H Hoffmann, H Fricke, et al.
Der Internist|June 13, 2001
[Diffuse localized lesions of brain MRI in a 33 year old female with cognitive impairments]M Schmidt, T Sitter, H Fricke, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Die Pharmazie|May 1, 1979
[Pharmacokinetics of turimycin (proceedings)]H Hoffmann, A Härtl, U Horn, et al.
The Journal of Antibiotics|June 1, 1978
Effect of demycarosylturimycin on ribosomal peptidyltransferase from Escherichia coliI Haupt, H Fricke, J Cerná, et al.
Journal of Environmental Monitoring : JEM|September 6, 2001
Comparison of two carbon analysis methods for monitoring diesel particulate levels in minesM E Birch, D Dahmann, H H Fricke
Kidney International|December 15, 2000
Proteinase 3 gene polymorphisms and Wegener's granulomatosisM Gencik, S Meller, S Borgmann, et al.
Die Pharmazie|January 1, 1976
[The physiology and biochemistry of Streptomycetes. 5. Isolation and identification of fatty acids from the macrolide antibiotic A 6599 (turimycin)]G Reuter, R Hüttner, H Fricke, et al.
Journal of Colloid and Interface Science|September 21, 2010
Clogging of microchannels by nano-particles due to hetero-coagulation in elongational flowK Georgieva, D J Dijkstra, H Fricke, et al.
Clinical and Experimental Immunology|July 15, 1999
Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patientsR F Schwabe, H Engelmann, S Hess, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Clinical aspects of biocompatibility]H Schiffl, S M Lang, C Keuneke, et al.
Die Pharmazie|November 1, 1983
[Protein binding of the macrolide antibiotic turimycin. Methodologic effects on results]G Hesse, H Hoffmann, H Fricke, et al.
Der Internist|June 13, 2001
[Diffuse localized lesions of brain MRI in a 33 year old female with cognitive impairments]M Schmidt, T Sitter, H Fricke, et al.
Pageof 12